Cargando…

ECMO for severe ARDS: systematic review and individual patient data meta-analysis

PURPOSE: To assess the effect of venovenous extracorporeal membrane oxygenation (ECMO) compared to conventional management in patients with severe acute respiratory distress syndrome (ARDS). METHODS: We conducted a systematic review and individual patient data meta-analysis of randomised controlled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Combes, Alain, Peek, Giles J., Hajage, David, Hardy, Pollyanna, Abrams, Darryl, Schmidt, Matthieu, Dechartres, Agnès, Elbourne, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537368/ https://www.ncbi.nlm.nih.gov/pubmed/33021684 http://dx.doi.org/10.1007/s00134-020-06248-3

Ejemplares similares

Morbidly obese with severe ARDS: ECMO or no ECMO?
por: Shalaby, Mohammed A.
Publicado: (2017)

Delivery decision in pregnant women rescued by ECMO for severe ARDS: a retrospective multicenter cohort study
por: Aissi James, Sarah, et al.
Publicado: (2022)

Expert consensus statement on venovenous extracorporeal membrane oxygenation ECMO for COVID-19 severe ARDS: an international Delphi study
por: Rabie, Ahmed A., et al.
Publicado: (2023)

Setting and Monitoring of Mechanical Ventilation During Venovenous ECMO
por: Assouline, Benjamin, et al.
Publicado: (2023)

Spontaneous hemothorax in 4 COVID-19 ARDS patients on VV-ECMO revealing pulmonary artery aneurysms
por: Desnos, Cyrielle, et al.
Publicado: (2020)

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases
por: Ramanathan, Kollengode, et al.
Publicado: (2020)

Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: Conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR)
por: Thalanany, Mariamma M, et al.
Publicado: (2008)

CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure
por: Peek, Giles J, et al.
Publicado: (2006)

ECMO for ARDS due to COVID-19
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

To prone or not to prone ARDS patients on ECMO
por: Roca, Oriol, et al.
Publicado: (2021)

Successful use of VV-ECMO in a pregnant patient with severe ARDS()()()
por: Carlier, Laurence, et al.
Publicado: (2019)

Characteristics and Outcomes of Severe ARDS Patients Receiving ECMO in Southern Thailand
por: Assanangkornchai, Nawaporn, et al.
Publicado: (2019)

Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID-19 ARDS in Sorbonne hospitals, Paris
por: Schmidt, Matthieu, et al.
Publicado: (2021)

ECMO, ARDS and AH1N1
por: Zangrillo, A
Publicado: (2009)

Case Report: Eculizumab and ECMO Rescue Therapy of Severe ARDS in Goodpasture Syndrome
por: Sobotta, Michael, et al.
Publicado: (2021)

Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs
por: Friedrichson, Benjamin, et al.
Publicado: (2021)

Role of VA ECMO in septic shock: Does it work?
por: Combes, Alain
Publicado: (2017)

Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores
por: Schmidt, Matthieu, et al.
Publicado: (2021)

COVID-19 trials were not more likely to report intent to share individual data than non-COVID-19 trials in ClinicalTrials.gov
por: Ramdjee, Bruno, et al.
Publicado: (2023)

The advent of ECMO and pumpless extracorporeal lung assist in ARDS
por: Hamid, I A, et al.
Publicado: (2011)

ARDS from miliary tuberculosis successfully treated with ECMO
por: Vesteinsdottir, Edda, et al.
Publicado: (2019)

Successful repeat ECMO in a patient with AIDS and ARDS
por: Horikita, Sho, et al.
Publicado: (2017)

Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients
por: Sylvestre, Aude, et al.
Publicado: (2019)

HYPONATREMIA SECONDARY TO VASOPRESSIN IN AN ECMO DEPENDENT PATIENT WITH SEVERE ARDS DUE TO COVID-19
por: HAFEEZ, ZEESHAN, et al.
Publicado: (2021)

What’s new in ECMO for COVID-19?
por: MacLaren, Graeme, et al.
Publicado: (2020)

ECMO during the COVID-19 pandemic: When is it justified?
por: Heinsar, Silver, et al.
Publicado: (2020)

Extracorporeal membrane oxygenation (ECMO) and the acute respiratory distress syndrome (ARDS): a systematic review of pre-clinical models
por: Millar, Jonathan E., et al.
Publicado: (2019)

Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome
por: Moyon, Quentin, et al.
Publicado: (2022)

ECMO during the COVID-19 pandemic: when is it unjustified?
por: Abrams, Darryl, et al.
Publicado: (2020)

Prone positioning monitored by electrical impedance tomography in patients with severe acute respiratory distress syndrome on veno-venous ECMO
por: Franchineau, Guillaume, et al.
Publicado: (2020)

Use of ECMO in ARDS: does the EOLIA trial really help?
por: Gattinoni, Luciano, et al.
Publicado: (2018)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

Severe ARDS caused by adenovirus: early initiation of ECMO plus continuous renal replacement therapy
por: Ha, Sang Ook, et al.
Publicado: (2016)

Re: Insight into ECMO, mortality and ARDS: a nationwide analysis of 45,647 ECMO runs (Friedrichson et al., Critical Care, January 2021)
por: Warren, Alex, et al.
Publicado: (2021)

The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox
por: Balik, M., et al.
Publicado: (2022)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO
por: Hraiech, Sami, et al.
Publicado: (2019)

Evaluation of right ventricular function and driving pressure with blood gas analysis could better select patients eligible for VV ECMO in severe ARDS
por: Petit, Matthieu, et al.
Publicado: (2021)

Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
por: Prohaska, Stefanie, et al.
Publicado: (2018)

Herpesviridae reactivation for poor outcome in ARDS patients with ECMO: criminal or witness?
por: Huang, Huixue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vfqr1ndd1g8o4ig0inu6civkke